COVID-19 Vaccine mRNABNT162b2 Elicits Human Antibody Response in Milk of Breastfeeding Women.

Maurizio GuidaDaniela TerraccianoMichele CennamoFederica AielloEvelina La CivitaGennaro EspositoValentina GargiuloGiuseppe M MaruottiGiuseppe PortellaLaura Sarno

Published in: Vaccines (2021)

We demonstrated a release of anti-SARS-CoV-2 S antibodies in the breast milk of women vaccinated with mRNABNT162b2. Vaccinating breastfeeding women could be a strategy to protect their infants from COVID-19 infection.

Keyphrases

sars cov
polycystic ovary syndrome
pregnancy outcomes
coronavirus disease
preterm infants
cervical cancer screening
endothelial cells
breast cancer risk
respiratory syndrome coronavirus
pregnant women
insulin resistance